What does FACIT invest in?
FACIT invests most often at Series A and Series B (100% of the rounds on record), in sectors such as Oncology, Biotech and Life Sciences.

Canada · Investor
Last cheque observed Apr 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietVC firm
2 rounds on record
Mostly Series A and Series B: 100% of its rounds
FACIT was established by the Ontario Institute for Cancer Research (OICR) to support commercialization, technology transfer, and development activities.From their own website
Every round we can evidence, newest first2 appearances
1 round
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
We hold 3 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
The investors most often in the same rounds as FACIT. A count of rooms they were both in, not a relationship either has claimed.
The latest companies FACIT put money into.
FACIT invests most often at Series A and Series B (100% of the rounds on record), in sectors such as Oncology, Biotech and Life Sciences.
2 investments on record, 0 of them in the last 12 months. The most recent was in Apr 2019.
Its most recent investments on record: Fusion Pharamaceuticals (Series B, Apr 2019) and Fusion Pharmaceuticals (Series A, Feb 2017).
The median round it joins is $65M.
No investments in the last 12 months; the latest was in Apr 2019.
Most often TPG (2 rounds together).
FACIT is a VC firm based in Toronto, Canada.
FACIT was founded in 2014.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it